Kai Schiemann

1.4k total citations
17 papers, 453 citations indexed

About

Kai Schiemann is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Kai Schiemann has authored 17 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Kai Schiemann's work include Asymmetric Synthesis and Catalysis (6 papers), Synthetic Organic Chemistry Methods (4 papers) and Chemical Synthesis and Analysis (3 papers). Kai Schiemann is often cited by papers focused on Asymmetric Synthesis and Catalysis (6 papers), Synthetic Organic Chemistry Methods (4 papers) and Chemical Synthesis and Analysis (3 papers). Kai Schiemann collaborates with scholars based in Germany, United States and United Kingdom. Kai Schiemann's co-authors include Lutz F. Tietze, Hollis D. Showalter, Marilyn M. Olmstead, Joseph Keane, Hongbo Deng, Joseph P. Konopelski, Djordje Müsil, Dániel Schwarz, Paul Czodrowski and Dirk Wienke and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Kai Schiemann

17 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Schiemann Germany 12 282 200 88 44 39 17 453
Michaël Prakesch Canada 15 324 1.1× 287 1.4× 64 0.7× 56 1.3× 46 1.2× 25 609
Bernard Marquet France 13 397 1.4× 194 1.0× 70 0.8× 68 1.5× 45 1.2× 28 663
Rabindranath Tripathy United States 14 425 1.5× 212 1.1× 60 0.7× 19 0.4× 80 2.1× 18 610
Italo Beria Italy 15 240 0.9× 289 1.4× 107 1.2× 18 0.4× 78 2.0× 22 485
Richard Ducray France 13 371 1.3× 208 1.0× 93 1.1× 35 0.8× 12 0.3× 17 554
Christopher M. Tegley United States 17 290 1.0× 255 1.3× 43 0.5× 28 0.6× 20 0.5× 22 667
Paul A. Renhowe United States 18 617 2.2× 412 2.1× 83 0.9× 37 0.8× 57 1.5× 26 891
Matthew A. Marx United States 13 378 1.3× 342 1.7× 66 0.8× 14 0.3× 17 0.4× 40 632
Chinatsu Ikeura Japan 7 246 0.9× 146 0.7× 100 1.1× 12 0.3× 31 0.8× 9 397
Muralidhar R. Mallireddigari United States 12 457 1.6× 212 1.1× 87 1.0× 15 0.3× 48 1.2× 14 646

Countries citing papers authored by Kai Schiemann

Since Specialization
Citations

This map shows the geographic impact of Kai Schiemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Schiemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Schiemann more than expected).

Fields of papers citing papers by Kai Schiemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Schiemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Schiemann. The network helps show where Kai Schiemann may publish in the future.

Co-authorship network of co-authors of Kai Schiemann

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Schiemann. A scholar is included among the top collaborators of Kai Schiemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Schiemann. Kai Schiemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schiemann, Kai, Kalyan C. Nallaparaju, Carsten Boesler, et al.. (2024). Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo. Molecular Cancer Therapeutics. 23(11). 1517–1529. 6 indexed citations
2.
Zaynagetdinov, Rinat, Kai Schiemann, Kalyan C. Nallaparaju, et al.. (2022). Abstract 3499: M1069 as dual A2A/A2B adenosine receptor antagonist counteracts immune-suppressive mechanisms of adenosine and reduces tumor growth in vivo. Cancer Research. 82(12_Supplement). 3499–3499. 7 indexed citations
3.
4.
Fuchß, Thomas, Kai Schiemann, Daniel Kühn, et al.. (2019). Abstract 3500: Highly potent and selective ATM kinase inhibitor M4076: A clinical candidate drug with strong anti-tumor activity in combination therapies. Cancer Research. 79(13_Supplement). 3500–3500. 11 indexed citations
5.
Schiemann, Kai, Aurélie Mallinger, Dirk Wienke, et al.. (2016). Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore. Bioorganic & Medicinal Chemistry Letters. 26(5). 1443–1451. 30 indexed citations
6.
Czodrowski, Paul, Aurélie Mallinger, Dirk Wienke, et al.. (2016). Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening. Journal of Medicinal Chemistry. 59(20). 9337–9349. 89 indexed citations
7.
Adeniji-Popoola, Olajumoke, Aurélie Mallinger, Sharon Gowan, et al.. (2016). Abstract 4355: Elucidation of the different roles of CDK8 and CDK19 in colorectal cancer (CRC) using CRISPR gene editing technology. Cancer Research. 76(14_Supplement). 4355–4355. 1 indexed citations
8.
Schiemann, Kai, Dirk Finsinger, Frank T. Zenke, et al.. (2010). The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5. Bioorganic & Medicinal Chemistry Letters. 20(5). 1491–1495. 56 indexed citations
9.
Heinrich, Timo, Henning Böttcher, Kai Schiemann, et al.. (2004). Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity. Bioorganic & Medicinal Chemistry. 12(18). 4843–4852. 36 indexed citations
10.
Schiemann, Kai & Hollis D. Showalter. (1999). Development of Polymer-Supported Benzotriazole as a Novel Traceless Linker for Solid-Phase Organic Synthesis1. The Journal of Organic Chemistry. 64(13). 4972–4975. 30 indexed citations
11.
Tietze, Lutz F., et al.. (1998). Synthesis of Enantiopure Homoallylic Alcohols. Chemistry - A European Journal. 4(9). 1862–1869. 16 indexed citations
12.
Tietze, Lutz F., et al.. (1998). Mechanistic Investigations on the Highly Stereoselective Allylation of Aldehydes with a Norpseudoephedrine Derivative. Journal of the American Chemical Society. 120(18). 4276–4280. 22 indexed citations
13.
Konopelski, Joseph P., Hongbo Deng, Kai Schiemann, Joseph Keane, & Marilyn M. Olmstead. (1998). Stereoselective Conjugate Addition Directed by an Enantiomerically Pure Ketal. Preparation of the Cyclohexanone Fragment of N-Methylwelwitindolinone C Isothiocyanate. Synlett. 1998(10). 1105–1107. 39 indexed citations
14.
Tietze, Lutz F., et al.. (1996). Synthesis of Enantiopure Homoallylic Alcohols and Ethers by Diastereoselective Allylation of Aldehydes. Chemistry - A European Journal. 2(9). 1164–1172. 24 indexed citations
15.
Tietze, Lutz F., et al.. (1995). Enantioselective Synthesis of Tertiary Homoallylic Alcohols via Diastereoselective Addition of Allylsilanes to Ketones. Journal of the American Chemical Society. 117(21). 5851–5852. 52 indexed citations
16.
Tietze, Lutz F., et al.. (1992). Diastereoselektive Addition von Allylsilanen an Aldehyde zur Synthese von enantiomerenreinen Homoallylalkoholen. Angewandte Chemie. 104(10). 1366–1367. 12 indexed citations
17.
Tietze, Lutz F., et al.. (1992). Diastereoselective Addition of Allylsilanes to Aldehydes: Synthesis of Enantiomerically Pure Homoallylic Alcohols. Angewandte Chemie International Edition in English. 31(10). 1372–1373. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaël Prakesch Breakdown of academic impact, for papers by Bernard Marquet Breakdown of academic impact, for papers by Rabindranath Tripathy Breakdown of academic impact, for papers by Italo Beria Breakdown of academic impact, for papers by Richard Ducray Breakdown of academic impact, for papers by Christopher M. Tegley Breakdown of academic impact, for papers by Paul A. Renhowe Breakdown of academic impact, for papers by Matthew A. Marx Breakdown of academic impact, for papers by Chinatsu Ikeura Breakdown of academic impact, for papers by Muralidhar R. Mallireddigari
Rankless by CCL
2026